Medical scar-repairing silicone gel dressing and preparation method thereof

A silicone gel and scar technology, used in medical science, bandages, absorbent pads, etc., can solve problems such as hand dysfunction, deformity, poor ability to take medicine on time, and inapplicability for patients who often use hands, etc. Achieve the effect of reducing the intensity of scar contracture, inhibiting excessive contraction and preventing scar contracture

Inactive Publication Date: 2019-10-08
GUANGXI XINYE BIOLOGICAL TECH
View PDF6 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Due to burns, burns, crushing injuries, electric shocks, surgery and other causes of injury, scars are likely to remain after treatment for wounds with a depth of more than two degrees, and the hyperplasia of the remaining scars often leads to deformities. Scar contractures and deformities caused by deep burns on the hands It often causes hand dysfunction and brings inconvenience to the life and work of patients
[0003] Most existing anti-scar contracture methods are oral anti-contracture drugs or compression methods for prevention. It is not suitable for children and other patients who have poor self-control and cannot take medicine on time and often use their hands. Another example is that the patent No. CN207684095U discloses a scar The repair gel is characterized in that it is made of the following raw materials in parts by weight: 0.03-0.05 parts of heparin sodium, 0.04-0.06 parts of hyaluronic acid, 0.04-0.06 parts of aloe powder, 0.04-0.06 parts of grape seed extract, vitamin E0.05-0.15 parts, lavender oil 0.05-0.15 parts, bisabolol 0.12-0.25 parts, nicotinamide 0.35-0.7 parts, carbomer 0.6-0.8 parts, allantoin 0.8-1.3 parts, centella asiatica extract 0.8-1.3 parts of substance, 5-6.8 parts of glycerin, 1-1.4 parts of solubilizer, 0.2-0.8 parts of neutralizer, 0.05-0.15 parts of essence, 0.25-0.35 parts of preservative, 85-91 parts of water, but scar repair effect Not good, can not be effectively promoted

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] A medical scar repair silicone gel dressing, the medical scar repair silicone gel dressing consists of the following raw materials by weight percentage:

[0030] Dimethicone 7%, Emulsifier 3%, Gel Base 1%, Scar Lightening Factor 15%, Odor Corrector 0.5%, Bacteriostat 0.5%, Antipruritic 5%-10%, Anti-Contracture Drug 0.0005%, penetration enhancer 5%, buffer system and purified water balance,

[0031] Wherein, the anticontracture drug is a mixture of plant extracts, corticosteroid hormones and papaverine hydrochloride with a mass ratio of 1:1:1,

[0032] Wherein, the plant extract is the total asiaticoside extract and the onion extract with a mass ratio of 2:1,

[0033] Wherein, the corticosteroid hormone is a mixture composed of prednisone and dexamethasone with a mass ratio of 1:1.

[0034] Wherein, the emulsifier is a mixture of olive oil PEG-7 ester and lauryl polyoxyethylene ether phosphate monoethanolamine with a mass ratio of 1:1.

[0035] Wherein, the gel matrix...

Embodiment 2

[0048] A medical scar repair silicone gel dressing, the medical scar repair silicone gel dressing consists of the following raw materials by weight percentage:

[0049] Dimethicone 15%, Emulsifier 5%, Gel Base 2%, Scar Lightening Factor 10%, Odorant 0.1%, Bacteriostat 2%, Antipruritic 6%, Anticontracture Drug 0.005% , penetration enhancer 3%, buffer system and the balance of purified water,

[0050] The anticontracture drug is a mixture of plant extracts, corticosteroids, tranilast, papaverine hydrochloride, tubocurarine, and mevasone in a mass ratio of 3:1:1:1:1:1.

[0051] The plant extract is madecassoside extract and onion extract with a mass ratio of 3:2,

[0052] The corticosteroid was dexamethasone acetate.

[0053] Described emulsifier is polyethylene glycol 7-stearate.

[0054] The gel matrix is ​​carbomer.

[0055] The scar lightening factor is composed of epidermal growth factor, hyaluronic acid, TGC protease, allantoin and horse oil in a mass ratio of 2:1:1:2:1...

Embodiment 3

[0067] A medical scar repair silicone gel dressing, the medical scar repair silicone gel dressing consists of the following raw materials by weight percentage:

[0068] Dimethicone 20%, Emulsifier 15%, Gel Base 3%, Scar Lightening Factor 2%, Odor Corrector 0.3%, Bacteriostat 1%, Antipruritic 7%, Anticontracture Drug 0.05% , penetration enhancer 7%, buffer system and purified water balance,

[0069] The anticontracture drug is a mixture of plant extracts, corticosteroid hormones and papaverine hydrochloride in a mass ratio of 3:1:1,

[0070] The plant extracts are Centella asiaticoside extract and onion extract with a mass ratio of 1:1,

[0071] The corticosteroid is dexamethasone.

[0072] The emulsifier is polyethylene glycol 20-stearate.

[0073] The gel matrix is ​​CMC-Na.

[0074] The scar lightening factor is epidermal growth factor.

[0075] The odor correcting agent is sandalwood essence.

[0076] Described antibacterial agent is chlorhexidine acetate.

[0077] T...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of dressings, in particular to a medical scar-repairing silicone gel dressing and a preparation method thereof. The medical scar-repairing silicone gel dressing is made from, by weight, 5-30% of polydimethylsiloxane, 3-20% of an emulsifier, 0.5-5% of substrate gel, 1-15% of a scar fading factor, 0.01-0.5% of a deodorizer, 0.05-5% of an antibacterial agent, 5-10% of an antipruritic, 0.0001-0.1% of an anti-contracture drug, 0.05-10% of a penetration promoter, and the balance of a buffer solution system and purified water. The anti-contracture drug made with plant extracts, corticosteroid hormones, heparin sodium, papaverine hydrochloride and other smooth muscle relaxation drugs is embedded in gel, the smooth muscle relaxation drugs are absorbed bythe human body through transdermal absorption, excess contraction of myofibroblasts is inhibited, the force of scar contracture is lessened, and scar contracture is prevented accordingly.

Description

technical field [0001] The invention relates to the technical field of dressings, in particular to a silicone gel dressing for medical scar repair and a preparation method thereof. Background technique [0002] Due to burns, burns, crushing injuries, electric shocks, surgery and other causes of injury, scars are likely to remain after treatment for wounds with a depth of more than two degrees, and the hyperplasia of the remaining scars often leads to deformities. Scar contractures and deformities caused by deep burns on the hands Often cause hand dysfunction, bring inconvenience to patient's life and work. [0003] Most existing anti-scar contracture methods are oral anti-contracture drugs or compression methods for prevention. It is not suitable for children and other patients who have poor self-control and cannot take medicine on time and often use their hands. Another example is that the patent No. CN207684095U discloses a scar The repair gel is characterized in that it ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61L15/20A61L15/24A61L15/26A61L15/42A61L15/44
CPCA61L15/20A61L15/24A61L15/26A61L15/42A61L15/44A61L2300/30A61L2300/43C08L33/02C08L83/04
Inventor 黄舒琼
Owner GUANGXI XINYE BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products